Entidade Adjudicante / Contracting Authority: IBMC

Referência do Procedimento / File Reference number attributed by the contracting authority: AD 243/2017

Tipo de procedimento / Procedure type: Ajuste direto / Direct award

Ao Abrigo / Under de article: Alínea a) do n.º 1 do artigo 20º do Código dos Contratos Públicos (“CCP”) / Article 20, nr. 1, al. a), of the Public Contracts Code (“PCC”)

Tipo de Contrato / Type of contract: Aquisição de serviços / Purchase of services

Objeto / Object of the contract: Aquisição de Serviços de Sequenciação de Nova Geração (NGS) / Purchase of Next Generation Sequencing Services (NGS)

Objetivo / Purpose otf the acquisition:

A necessidade e o interesse do IBMC assegurar as condições necessárias ao desenvolvimento da respetiva atividade, financiado por fundos Amyloidosis Foundation (Amyloidosis Grant - New Biomarkers for FAP) e Pfizer (Res. agreement- WI216825("Study") - TR Amyloidosis Deciphering the genetic network associated with age-at-onset variability increasing awareness of genetic carriers);                                                                                                                                                              The need and interest of IBMC to ensure the necessary conditions for the development of its activity, financed by the Amyloidosis Foundation (Amyloidosis Grant - New Biomarkers for FAP) and Pfizer (Res. agreement- WI216825("Study") - TR Amyloidosis Deciphering the genetic network associated with age-at-onset variability increasing awareness of genetic carriers);

Entidades Convidadas / Suppliers Invited: BGI-Europe A/S

Data de abertura do procedimento / Date of opening of the procedure: 12/10/2017

Data limite de apresentação de propostas / Time limit for receipt of tenders: 19/10/2017

Preço Base / Basis price: 56 250,00€ Eur

Estado / State: Concluído